Dementia is the sixth leading cause of death in the USA. Of these top six, it is the only one increasing. One in eight over-65s is anticipated to develop dementia, according to a 2012 Alzheimer’s Association report.

Currently only 50% of all cases are successfully diagnosed before death. Current diagnosis is done by interviews with specialists through a neurological evaluation and further clinical examinations. These methods are slow (6 months on average), not easily accessible, expensive ($5k on average) and often made in the progressive stage of the disease development.

Our inexpensive, widely accessible, and objective solution is perfectly placed to cover the gap by proactively measuring mass population and identifying those with declining cognition. The collected information can be fed into the current diagnostic channels in order to increase their detection efficiency, which will turn the competition into partnership.